Cancer Research Cancer Epigenetics  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 109-114, January 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tweedie, J. W.
Right arrow Articles by Pitot, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tweedie, J. W.
Right arrow Articles by Pitot, H. C.

Polyadenylate-containing RNA of Polyribosomes Isolated from Rat Liver and Morris Hepatoma 78001

John W. Tweedie2 and Henry C. Pitot3

McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison, Wisconsin 53706

The fraction of polyribosomal RNA that contains polyadenylate sequences was examined in rat liver and the Morris hepatoma 7800. Sequential sodium dodecyl sulfatephenol extraction at pH 7.6 and pH 9.0 followed by polythymidylate cellulose chromatography of the fraction extracted at pH 9.0 was used to isolate the polyadenylate-containing fraction of polyribosomal RNA. This fraction from either tissue appeared to be the same with respect to mobility on acrylamide gels, sensitivity to ribonuclease digestion, and 32P base composition analysis. There was no difference in the absolute amount of polyadenylate-containing RNA in polyribosomes from either liver or hepatoma.

The time course of the decay in specific activity of the polyadenylate-containing RNA was determined following the administration of a single dose of 32P. From these data, a half-life of approximately 9 to 12 hr could be calculated for the polyadenylate-containing RNA fraction from both liver and the hepatoma polyribosomes.

1 The work described was supported in part by Grant CA-07175 from the National Cancer Institute and Grant E-588 from the American Cancer Society.

2 Present address: Department of Chemistry, Biochemistry and Biophysics, Massey University, Palmerston North, New Zealand.

3 To whom correspondence should be addressed.

Received 7/16/73. Accepted 10/ 2/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.